Personnel

Viral Genetics names Eric S. Rosenberg, MD, chairman of scientific advisory board

Published in AIDS Weekly, October 23rd, 2006

Eric S. Rosenberg, MD, associate professor of medicine at Harvard Medical School, has been appointed chairman of the scientific advisory board of Viral Genetics, Inc. (VRAL), an emerging biotechnology company that discovers and develops immune-based therapies for HIV and AIDS.

Based on the results of Viral Genetics' recent clinical trial, Rosenberg was appointed to a more active leadership role in the development of VGV-1 and thymus nuclear protein. He will be advising the company on future studies and the design of a clinical development strategy toward the commercialization of VGV-1 in the U.S.

Rosenberg succeeds Ronald Moss as the chairman of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2006-10-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry